| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $148.5M | +19.5% |
| R&D Expense | $500K | -50.0% |
| SG&A Expense | $44.1M | +6.6% |
| Operating Income | -$221.0M | -237.4% |
| Pre-tax Income | -$256.8M | -127.4% |
| Income Tax | $73K | +124.4% |
| Net Income | -$256.9M | -128.1% |
| EPS (Basic) | -$0.14 | -133.3% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.1M | +124.3% |
| Accounts Receivable | $26.3M | +24.3% |
| Inventory | $9.3M | -33.0% |
| Current Assets | $81.2M | +18.0% |
| Total Assets | $833.4M | +2.4% |
| Current Liabilities | $197.1M | +220.1% |
| Long-term Debt | $191.9M | -19.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.8M | -51.6% |
| Investing Cash Flow | -$40.0M | +11.6% |
| Financing Cash Flow | -$6.0M | +95.7% |
| -133.3% |
| Stockholders' Equity |
| $314.8M |
| -13.9% |